Human Molecular Genetics Advance Access originally published online on February 27, 2009
Human Molecular Genetics 2009 18(10):1813-1824; doi:10.1093/hmg/ddp098
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Analysis of Ellis van Creveld syndrome gene products: implications for cardiovascular development and disease
Division of Cardiology, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA
* To whom correspondence should be addressed. Tel: +1 5136367716; Fax: +1 5136362410; Email: woody.benson{at}cchmc.org
Received October 18, 2008; Accepted February 25, 2009
Mutations identified in a cohort of patients with atrioventricular septal defects as a part of Ellis van Creveld syndrome (EvC syndrome) led us to study the role of two non-homologous genes, EVC and LBN, in heart development and disease pathogenesis. To address the cause of locus heterogeneity resulting in an indistinguishable heart–hand phenotype, we carried out in situ hybridization and immunofluorescence and identified co-localization of Evc and Lbn mRNA and protein. In the heart, expression was identified to be strongest in the secondary heart field, including both the outflow tract and the dorsal mesenchymal protrusion, but was also found in mesenchymal structures of the atrial septum and the atrioventricular cushions. Finally, we studied the transcriptional hierarchy of EVC and LBN but did not find any evidence of direct transcriptional interregulation between the two. Due to the locus heterogeneity of human mutations predicted to result in a loss of protein function, a bidirectional genomic organization and overlapping expression patterns, we speculate that these proteins function coordinately in cardiac development and that loss of this coordinate function results in the characteristics of EvC syndrome.